| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/30/2014 | CN102731658B 一种Tat PTD-Endostatin重组蛋白及其制备方法与应用 One kind of Tat PTD-Endostatin recombinant protein and its preparation method and application |
| 07/30/2014 | CN102731343B 氮原子多取代的芳香酰胺类小分子有机化合物及其衍生物、用途及其制备方法 A nitrogen atom substituted aromatic amides and more small molecule organic compounds and derivatives thereof, the use and preparation method |
| 07/30/2014 | CN102712655B 小檗胺的二酰亚胺化衍生物、其制备方法和应用 Berbamine imide derivatives, and its preparation method and application |
| 07/30/2014 | CN102688499B 白蛋白—聚乙二醇—药物分子偶联物 Albumin - polyethylene glycol - a drug molecule conjugates |
| 07/30/2014 | CN102633732B 一类酞嗪酮衍生物及其应用 A class of derivatives and their application -phthalazinon |
| 07/30/2014 | CN102618547B 一种富含鸟嘌呤的核酸适体 A rich source of guanine aptamers |
| 07/30/2014 | CN102614127B 一种白藜芦醇纳米分散体及其制备方法 One kind of resveratrol and its preparation method nanodispersions |
| 07/30/2014 | CN102557977B 埃罗替尼的合成中间体及其制备方法 Synthetic intermediates and preparation method erlotinib |
| 07/30/2014 | CN102516361B Nrp-1配体多肽-聚乙二醇-磷脂复合物、其介导的主动靶向脂质体递药系统及其制备方法 Nrp-1 ligand peptide - polyethylene glycol - phospholipid complex, active targeting liposome-mediated drug delivery of its system and its preparation method |
| 07/30/2014 | CN102421827B 具有羟基的生理活性物质的高分子结合体 Polymer having a physiologically active substance a combination of a hydroxyl group |
| 07/30/2014 | CN102408429B 抑制醛甾酮合酶和芳香酶的稠合咪唑衍生物 Inhibition of aldosterone synthase and aromatase enzyme fused imidazole derivatives |
| 07/30/2014 | CN102388048B 三唑并[4，3-b]哒嗪衍生物及其用于前列腺癌的用途 Triazolo [4,3-b] pyridazine derivatives and their use for prostate cancer |
| 07/30/2014 | CN102358752B 与GLP-1和肠促胰岛素类似物(exendin)有关的发明 And GLP-1 and incretin analogues (exendin) related inventions |
| 07/30/2014 | CN102292069B 囊泡制剂 Vesicle preparation |
| 07/30/2014 | CN102209727B 抗TGF-β受体II抗体 Anti-TGF-β receptor II antibody |
| 07/30/2014 | CN102170873B 用于治疗与hedgehog通路有关的病症的smoothened拮抗 Hedgehog pathway for the treatment of disorders associated smoothened antagonist |
| 07/30/2014 | CN102131782B 作为vegf-2受体和蛋白酪氨酸激酶抑制剂的吡啶衍生物 Pyridine derivatives as vegf-2 receptor protein tyrosine kinase inhibitors |
| 07/30/2014 | CN102112145B 神经内分泌病的抑制 Inhibition of neuroendocrine disease |
| 07/30/2014 | CN102066362B 二氢吲哚酮衍生物 Indolinone derivatives |
| 07/30/2014 | CN102040570B 硫代紫杉烷类衍生物及其制备方法和用途 Thiosulfate taxane derivatives, preparation method and uses |
| 07/30/2014 | CN101987865B 含有乙内酰脲结构的促黄体生成素释放激素拮抗剂 Luteinizing containing hydantoin structures generate hormone releasing hormone antagonist |
| 07/30/2014 | CN101965342B N-[2-(二乙基氨基)乙基]-5-[(5-氟-1,2-二氢-2-氧代-3h-吲哚-3-亚基)甲基]-2,4-二甲基-1h-吡咯-3-甲酰胺的晶型及其制备方法 N- [2- (diethylamino) ethyl] -5 - [(5-fluoro-1,2-dihydro-2-oxo -3h- indol-3-ylidene) methyl] -2 , 4-dimethyl-pyrrole-3-carboxylic acid polymorph -1h- and preparation method of the amide |
| 07/30/2014 | CN101939027B 用于递送核酸的脂肽 Lipopeptides for delivery of nucleic acids |
| 07/30/2014 | CN101910168B 托烷化合物 Tropane compound |
| 07/30/2014 | CN101885770B 一种特异性结合cd15的全人源抗体及应用 One kind of specific binding cd15 fully human antibodies and application |
| 07/30/2014 | CN101820762B 透过抑制极光激酶而用于治疗癌症的吡咯并三嗪衍生物 Pyrrole through inhibition of aurora kinases for the treatment of cancer and triazine derivatives |
| 07/30/2014 | CN101801965B 作为细胞坏死抑制剂的吲哚化合物 As the indole compound necrosis inhibitor |
| 07/30/2014 | CN101641013B 核受体结合剂 Nuclear receptor binding agent |
| 07/30/2014 | CN101528677B Hdac抑制剂 Hdac inhibitors |
| 07/29/2014 | US8791263 Cortistatin A analog and use thereof |
| 07/29/2014 | US8791131 Imidazo[1,5]naphthyridine compounds, their pharmaceutical use and compositions |
| 07/29/2014 | US8791102 Acetanilide sphingosine-1-phosphate receptor antagonists |
| 07/29/2014 | US8791081 MGMT inhibitor combination for the treatment of neoplastic disorders |
| 07/29/2014 | US8790934 Nanoparticles |
| 07/29/2014 | US8790882 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 07/29/2014 | CA2691033C Capsid proteins and uses therefore |
| 07/29/2014 | CA2673683C Compounds and method for treatment of cancer |
| 07/29/2014 | CA2655398C 4-amino-3-(3-azolyl-phenoxymethyl)-thieno[3,2-c]pyridine-7-carboxylic acid derivatives and uses thereof for treating cancer, atherosclerosis and restenosis |
| 07/29/2014 | CA2650057C Phenyl- or pyridinyl-amide as inhibitors of c-fms kinase |
| 07/29/2014 | CA2610281C Therapeutic agent for cancer |
| 07/29/2014 | CA2602328C Imidazo[1,2-a]pyridine derivatives: preparation and pharmaceutical applications |
| 07/29/2014 | CA2593993C Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases |
| 07/29/2014 | CA2592249C Binding proteins specific for human matriptase |
| 07/29/2014 | CA2564603C Therapeutic compositions containing at least one pyrrolobenzodiazepine derivative and fludarabine |
| 07/29/2014 | CA2555507C Use of proton pump inhibitors for the treatment of cancer conditions |
| 07/29/2014 | CA2541405C The use of a polyphenol for the treatment of a cancerous or pre-cancerous lesion of the skin |
| 07/29/2014 | CA2537161C Preventive cancer vaccine based on brother of regulator of imprinted sites molecule (boris) |
| 07/29/2014 | CA2494974C Il-7 drug substance, composition, preparation and uses |
| 07/29/2014 | CA2473289C Asymmetric urea compounds useful as naaladase and psma imaging agents |
| 07/29/2014 | CA2455365C Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 07/24/2014 | WO2014113616A1 Process for preparing the anti-tumor agent 6-(7-((1-aminocyclopropyl) methoxy)-6-methoxyquinolin-4-yloxy)-n-methyl-1-naphthamide and its crystalline |
| 07/24/2014 | WO2014113609A1 Stable indole-3-propionate salts of s-adenosyl-l-methionine |
| 07/24/2014 | WO2014113485A1 Lysophosphatidic acid receptor antagonists |
| 07/24/2014 | WO2014113467A1 Stat3 inhibitor |
| 07/24/2014 | WO2014113415A1 Reprogramming of human endothelium into hematopoietic multi-lineage progenitors by defined factors |
| 07/24/2014 | WO2014113413A1 Bcl-2bcl-xl inhibitors and therapeutic methods using the same |
| 07/24/2014 | WO2014113406A1 Compositions and methods for treating pancreatic cancer |
| 07/24/2014 | WO2014113388A1 Thiazolecarboxamides and pyridinecarboxamide compounds useful as pim kinase inhibitors |
| 07/24/2014 | WO2014113260A1 Androgen receptor modulator and uses thereof |
| 07/24/2014 | WO2014113167A1 Non-invasive imaging methods for patient selection for treatment with nanoparticulate therapeutic agents |
| 07/24/2014 | WO2014112955A1 Use of selective delta-opioid receptor antagonists and specific sensory receptor ligands |
| 07/24/2014 | WO2014111957A1 Nitric oxide releasing prodrugs of therapeutic agents |
| 07/24/2014 | WO2014111871A1 4,5-dihydroisoxazole derivatives as nampt inhibitors |
| 07/24/2014 | WO2014111584A1 Methods of treatment of fibrosis and cancers |
| 07/24/2014 | WO2014111380A1 Novel compound useful for the treatment of degenerative and inflammatory diseases |
| 07/24/2014 | WO2014111069A1 Helquat derivatives, preparation thereof, and use thereof as medicaments |
| 07/24/2014 | WO2014083567A3 Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors |
| 07/24/2014 | WO2014083019A3 Agent for modulating the dissemination of cancer cells, product comprising said agent, and use of said agent in the treatment and/or prevention of cancer |
| 07/24/2014 | WO2014081346A3 Method for cancer immunotherapy and pharmaceutical compositions based on oncolytic non-pathogenic sendai virus |
| 07/24/2014 | WO2014062659A3 Methods of treating ocular diseases |
| 07/24/2014 | US20140206865 Human Adam-10 Inhibitors |
| 07/24/2014 | US20140206691 Cyclic protein tyrosine kinase inhibitors |
| 07/24/2014 | US20140206641 Remedy |
| 07/24/2014 | US20140205672 Release control compositions |
| 07/24/2014 | US20140205657 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 07/24/2014 | US20140205544 Cancer Treatment Comprising Therapeutics That Bind To Phosphatidylserine |
| 07/23/2014 | EP2757152A1 Method for inhibiting cell growth, nucleic acid molecule having rna interference effect on nek10 variant gene, and anticancer agent |
| 07/23/2014 | EP2757105A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 07/23/2014 | EP2757099A1 Apoptosis promoters |
| 07/23/2014 | EP2755977A1 6, 8- disubstituted purine compositions and their pharmaceutical and cosmetic use |
| 07/23/2014 | EP2755976A1 6 - substituted 3 - (quinolin- 6 - ylthio) - [1,2,4]triazolo [4, 3 -a]pyradines as tyrosine kinase |
| 07/23/2014 | EP2755975A1 New enzyme inhibitor compounds |
| 07/23/2014 | EP2755958A1 Aminopyrimidine derivatives for use as modulators of kinase activity |
| 07/23/2014 | EP2755956A1 Disubstituted 5-fluoro-pyrimidines |
| 07/23/2014 | EP2755948A1 Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group |
| 07/23/2014 | EP2755942A2 Therapeutic compounds |
| 07/23/2014 | EP2755940A1 Anticancer active ingredient derived from guiera senegalensis |
| 07/23/2014 | EP2755674A1 Antagonists of products of the hs.459642 unigene cluster for the inhibition of proliferation, development or differentiation of stem cells including cancer stem cells |
| 07/23/2014 | EP2755665A1 A particulate system for use in diminishing cell growth/inducing cell killing |
| 07/23/2014 | EP2755662A1 Combination therapy using ribavirin as eif4e inhibitor |
| 07/23/2014 | EP2755659A2 Pharmaceutical nanoparticle compositions |
| 07/23/2014 | EP2755655A1 Use of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one in the treatment of cancer in moderate hepatic impaired patients |
| 07/23/2014 | EP2755654A1 Phosphatidylinositol 3-kinase inhibitors for the treatment of cancer |
| 07/23/2014 | EP2755653A1 Compositions and methods for treating cancer using pi3k beta inhibitor and mapk pathway inhibitor, including mek and raf inhibitors |
| 07/23/2014 | EP2755650A1 Use of 3-(r)-[3-(2-methoxyphenylthio)-2-(s)-methylpropyl]amino-3,4-dihydro- 2h-1,5-benzoxathiepine for treating cancer and in particular for preventing and/or treating cancer metastases |
| 07/23/2014 | EP2755648A1 Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof |
| 07/23/2014 | EP2755643A1 Compositions of jasmonate compounds and methods of use |
| 07/23/2014 | CN1833030B 用于表达、传递及纯化目标多肽的重组载体分子 Expression vectors used in recombinant molecules, and purification of the target polypeptide is passed |
| 07/23/2014 | CN103946242A 抗cd22嵌合抗原受体 Anti-cd22 chimeric antigen receptor |
| 07/23/2014 | CN103946239A 用于治疗b细胞慢性淋巴细胞性白血病和其他恶性血液病的cd44单克隆抗体 Cd44 for the treatment of b-cell chronic lymphocytic leukemia and other hematologic malignancies monoclonal antibody |